HETEROBICYCLOARYL RORC2 INHIBITORS AND METHODS OF USE THEREOF
The present invention provides compounds, pharmaceutical compositions, methods of inhibiting RORy activity and/or reducing the amount of IL-17 in a subject, and methods of treating various medical disorders using such compounds and pharmaceutical compositions.
Saved in:
| Main Authors | , , , , , , , , , , , , , |
|---|---|
| Format | Patent |
| Language | English Serbian |
| Published |
30.11.2018
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The present invention provides compounds, pharmaceutical compositions, methods of inhibiting RORy activity and/or reducing the amount of IL-17 in a subject, and methods of treating various medical disorders using such compounds and pharmaceutical compositions. |
|---|---|
| AbstractList | The present invention provides compounds, pharmaceutical compositions, methods of inhibiting RORy activity and/or reducing the amount of IL-17 in a subject, and methods of treating various medical disorders using such compounds and pharmaceutical compositions. |
| Author | ZAMARATSKI, EDOUARD WENNERSTÅL, GÖRAN MATTIAS BLINN, JAMES ROBERT MENTE, SCOT RICHARD SCHNUTE, MARK EDWARD ZAPF, CHRISTOPH WOLFGANG FLICK, ANDREW CHRISTOPHER KURUMBAIL, RAVI G JONES, PETER KIEFER, JAMES RICHARD JR MEYERS, MARVIN JAY THORARENSEN, ATLI XING, LI KAILA, NEELU |
| Author_xml | – fullname: JONES, PETER – fullname: THORARENSEN, ATLI – fullname: WENNERSTÅL, GÖRAN MATTIAS – fullname: ZAPF, CHRISTOPH WOLFGANG – fullname: MEYERS, MARVIN JAY – fullname: MENTE, SCOT RICHARD – fullname: SCHNUTE, MARK EDWARD – fullname: BLINN, JAMES ROBERT – fullname: FLICK, ANDREW CHRISTOPHER – fullname: XING, LI – fullname: KURUMBAIL, RAVI G – fullname: ZAMARATSKI, EDOUARD – fullname: KAILA, NEELU – fullname: KIEFER, JAMES RICHARD JR |
| BookMark | eNrjYmDJy89L5WSw9XANcQ3yd_J0jnT28XcMivRRCPIPcjZS8PTz8HTyDPEPClZw9HNR8HUN8fB3CVbwd1MIDXZVCPFwDXL1d-NhYE1LzClO5YXS3Axybq4hzh66qQX58anFBYnJqXmpJfFBwabmZoYWTobGBBUAAFU8Kps |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | HETEROBICIKLOARIL RORC2 INHIBITORI I POSTUPCI ZA NJIHOVU UPOTREBU |
| ExternalDocumentID | RS57618B1 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_RS57618B13 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 14:54:48 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English Serbian |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_RS57618B13 |
| Notes | Application Number: RS2018P001058 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20181130&DB=EPODOC&CC=RS&NR=57618B1 |
| ParticipantIDs | epo_espacenet_RS57618B1 |
| PublicationCentury | 2000 |
| PublicationDate | 20181130 |
| PublicationDateYYYYMMDD | 2018-11-30 |
| PublicationDate_xml | – month: 11 year: 2018 text: 20181130 day: 30 |
| PublicationDecade | 2010 |
| PublicationYear | 2018 |
| RelatedCompanies | PFIZER INC |
| RelatedCompanies_xml | – name: PFIZER INC |
| Score | 3.1754138 |
| Snippet | The present invention provides compounds, pharmaceutical compositions, methods of inhibiting RORy activity and/or reducing the amount of IL-17 in a subject,... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | HETEROBICYCLOARYL RORC2 INHIBITORS AND METHODS OF USE THEREOF |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20181130&DB=EPODOC&locale=&CC=RS&NR=57618B1 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1Lb8IwDLYQm7bdNvZ-oBym3tBGW1o4VBNNU7UTNCgtE5xQCu20CyDotL8_pyvbLtysRLKcSF8-20lsgEekQL2NtNrSU9tQ2Sq7JRd6DyXVhzuXCCmV0B9GVjA2XyedSQ3ed39hyjqhX2VxRETUHPFelOf1-i-J5ZVvK7dP6QcOrV78xPG0KjpGusIzWfNch424x6lGqSNiLRIOutXtroth0gH60LaCAntz1ZeU9X8-8U_hcISqlsUZ1LabBhzTXdu1BhwNq9tuFCvgbc_BCRj6ndwN6ZQOeF9MB0RwQXUSRkHohgkXMelHHhmyJOBeTLhPxjEjScAE4_4FNH2W0KCFdsx-VzwTcWWvcQn15WqZXQORZk9mlpUZUrXGSDNp2M8yT2Vn0TVzwzJv4GqPktu9M3dwojbtp5ThPdSLzWf2gCRbpM1yg74Bsq58Rw |
| link.rule.ids | 230,309,783,888,25576,76876 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3dT8IwEL8QNOKb4vcH9sHsjSjb2OBhMazrsum2km4YeCKdDOMLEJjx3_c2h_rC26VNLtcmv_7uru0dwD1SoNpBWm2rqakV2SqzLWdqH6WiD_dcIqSKhH4YGd5Ifx53xzV43_6FKeuEfpXFERFRb4j3vDyvV39JLKd8W7l5SD9waPnkJpajVNEx0hWeyYpjW2zIHU4VSi0RK5Gw0K3u9GwMk_bQvzYLKLBXu_iSsvrPJ-4R7A9R1SI_htpm3YQG3bZda8JBWN12o1gBb3MClsfQ7-S2Tyc04AMxCYjggqrEjzzf9hMuYjKIHBKyxONOTLhLRjEjiccE4-4ptFyWUK-Ndkx_VzwVcWWvdgb1xXKRXQCRel9mhpFpsmiNkWZSMx_lPJXdWU-fa4Z-Cec7lFztnLmDhpeEwTTwo5drOCw28Kes4Q3U8_VndouEm6etcrO-AbITfzo |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=HETEROBICYCLOARYL+RORC2+INHIBITORS+AND+METHODS+OF+USE+THEREOF&rft.inventor=JONES%2C+PETER&rft.inventor=THORARENSEN%2C+ATLI&rft.inventor=WENNERST%C3%85L%2C+G%C3%96RAN+MATTIAS&rft.inventor=ZAPF%2C+CHRISTOPH+WOLFGANG&rft.inventor=MEYERS%2C+MARVIN+JAY&rft.inventor=MENTE%2C+SCOT+RICHARD&rft.inventor=SCHNUTE%2C+MARK+EDWARD&rft.inventor=BLINN%2C+JAMES+ROBERT&rft.inventor=FLICK%2C+ANDREW+CHRISTOPHER&rft.inventor=XING%2C+LI&rft.inventor=KURUMBAIL%2C+RAVI+G&rft.inventor=ZAMARATSKI%2C+EDOUARD&rft.inventor=KAILA%2C+NEELU&rft.inventor=KIEFER%2C+JAMES+RICHARD+JR&rft.date=2018-11-30&rft.externalDBID=B1&rft.externalDocID=RS57618B1 |